Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. (ENSC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENSC · as of Jun 9, 2026
Key Statistics
Explore Ensysce Biosciences, Inc. Data
ensc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
ensc competitorsENSC
AIM
CANF
KALA
KZIA
OGENStock Performance
Full HistoryAbout Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preve…
what is ensysce biosciences, inc. · ensc stock overview · ensysce biosciences, inc. company profile · who is ensysce biosciences, inc. ceo · ensc NASDAQ · ensysce biosciences, inc. headquarters · ensysce biosciences, inc. business segments
About Stock Overview & Key Data
Ensysce Biosciences, Inc. (ENSC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 14, 2018. As of the latest trading session, ENSC stock price is $0.25, with a market capitalization of $2.3M. The stock has returned -89.14% over the past 12 months and -72.50% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Ensysce Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Ensysce Biosciences, Inc. reported revenue of $5.1M and net income of -$10.2M. For detailed data — including Ensysce Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ensysce Biosciences, Inc. (ENSC) stock price is $0.25. The stock is traded on NASDAQ under the ticker symbol ENSC. The 52-week range is $0.23 – $2.75.